Novavax Inc (NVAX)

Cash & Equivalents

$191.46M

Quarterly · Period ending: · USD

NVAX logo

NVAX Cash & Equivalents

Latest reported$191.46M
NVAX Quarterly Cash & Equivalents ($3.90M → $191.46M)
High-resolution chart · PNG

NVAX cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
191,458,000
228,363,000
240,634,000
268,023,000
253,744,000
263,338,000
530,230,000
573,630,000
680,162,000
480,586,000
568,505,000
651,104,000
505,912,000
624,950,000
1,336,883,000
1,280,581,000
1,375,587,000
1,570,954,000
1,515,116,000
1,936,998,000
2,074,880,000
1,995,482,000
553,398,000
334,171,000
424,395,000
179,881,000
78,823,000
71,167,000
71,995,000
97,711,000
70,154,000
56,496,000
88,475,000
113,402,000
106,307,000
104,245,000
75,793,000
95,847,000
144,353,000
119,948,000
89,395,000
132,225,000
93,108,000
138,144,000
167,384,000
215,050,000
32,335,000
34,473,000
103,857,000
109,921,000
119,471,000
122,493,000
2,574,000
9,023,000
17,399,000
10,738,000
15,334,000
13,873,000
14,104,000
14,318,000
13,092,000
8,358,000
8,061,000
16,215,000
9,446,000
14,575,000
38,757,000
29,984,000
25,216,000
19,629,000
26,938,000
36,794,000
23,513,000
14,702,000
4,350,000
15,816,000
7,337,000
7,782,000
7,161,000
21,294,000
78,601,000
83,941,000
31,893,000
6,944,000
4,442,000
9,202,000
17,876,000
27,503,000
15,623,000
21,885,000
27,633,000
6,045,000
9,625,000
14,320,000
3,005,000
7,630,000
15,927,000
10,885,000
20,045,000
23,296,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.